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BACKGROUND: Studies on alcohol intake in relation to endometrial cancer risk have produced inconsistent results.
METHODS: For a meta-analysis, we identified cohort studies of alcohol and endometrial cancer by a literature search of Pub-Med and
Embase up to 1 March 2010 and by searching the reference lists of relevant articles.
RESULTS: Seven cohort studies, including 1511661 participants and 6086 endometrial cancer cases, were included in the dose–
response random-effect meta-regression model. Compared with non-drinkers, women drinking less than 1 drink of alcohol (13g of
ethanol) per day had a lower risk for endometrial cancer; this risk was lower by 4% (95% confidence interval (95% CI): 0.93–1.00) for
consumption up to 0.5 drink per day and by 7% (95% CI: 0.85–1.02) for consumption up to 1 drink. However, we found evidence of
an increased risk for endometrial cancer for intakes higher than two alcoholic drinks per day: compared with non-drinkers, the risk
was higher by 14% (95% CI: 0.95–1.36) for 2–2.5 drinks per day and by 25% (95% CI: 0.98–1.58) for 42.5 drinks per day.
CONCLUSION: Our meta-analysis indicates a possible J-shaped relationship between alcohol intake and endometrial cancer risk.
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Alcohol has been claimed to increase the risk of endometrial
cancer by increasing oestrogen levels (Gavaler and Van Thiel,
1992; Hankinson et al, 1995; Onland-Moret et al, 2005; Rinaldi
et al, 2006), which has been shown to increase endometrial cancer
risk (Graham and Clarke, 1997). However, a moderate alcohol
intake has also been shown to have a beneficial effect on insulin
sensitivity and insulin levels (Davies et al, 2002). Hyperinsulin-
aemia has been shown to stimulate endometrial cell proliferation
(Nagamani and Stuart, 1998).
Certain studies have reported an increased risk of endometrial
cancer in relation to alcohol intake (La Vecchia et al, 1986;
Parazzini et al, 1995; Terry et al, 1999; Setiawan et al, 2008);
one cohort and one case–control study reported a decreased
risk (Webster and Weiss, 1989; Folsom et al, 2003), whereas
others have not shown a significant association (Williams
and Horm, 1977; Cusimano et al, 1989; Kato et al, 1989; Austin
et al, 1993; Gapstur et al, 1993; Levi et al, 1993; Shu et al,
1993; Swanson et al, 1993; Kalandidi et al, 1996; Goodman
et al, 1997; Newcomb et al, 1997; Jain et al, 2000; Weiderpass
and Baron, 2001; Loerbroks et al, 2007; Hosono et al, 2008;
Kabat et al, 2008; Allen et al, 2009; Friberg and Wolk, 2009).
Of four studies on endometrial cancer or corpus uteri cancer
among alcoholics, one showed a decreased risk (Weiderpass et al,
2001), whereas the others, which had very few cases, showed
no significant results (Adami et al 1992; Tonnesen et al, 1994;
Sigvardsson et al, 1996).
To quantify the association between alcohol consumption
and endometrial cancer risk, we performed a dose–response
meta-analysis of prospective studies.
METHODS
Two persons (E Friberg and N Orsini) independently identified
studies by a literature search of the Pub-Med and Embase
databases (from their beginning through to 1 March 2010) with
the following subject heading terms and/or text words: ‘alcohol’,
‘alcoholic drink’, ‘liquor’, ‘beer’, ‘ethanol’, ‘endometrial cancer’,
‘corpus uteri’. They also reviewed reference lists of the identified
publications for additional studies. No language restrictions were
imposed.
Seven prospective population-based cohorts have reported on
alcohol intake in relation to endometrial cancer risk, and were
considered for inclusion in this meta-analysis (Gapstur et al, 1993;
Terry et al, 1999; Jain et al, 2000; Folsom et al, 2003; Loerbroks
et al, 2007; Kabat et al, 2008; Setiawan et al, 2008; Allen et al, 2009;
Friberg and Wolk, 2009); all reported dose–response data and
were included in dose–response analysis. In the case of multiple
publications, as from the Iowa Womens Health Cohort (Gapstur
et al, 1993; Folsom et al, 2003), the one supplying dose–response
data was chosen (Gapstur et al, 1993), and in the case of the
National Breast Screening Study in Canada (Jain et al, 2000;
Kabat et al, 2008), the one with the longest follow-up was chosen
(Kabat et al, 2008).
The data that we extracted included publication data (the first
author’s last name, year of publication, and country of which the
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ypopulation was studied), number of subjects, follow-up period,
risk estimates with their corresponding confidence intervals (CIs),
and variables controlled for in the multivariable model. From each
study, we extracted the risk estimates that reflected the greatest
degree of control for potential confounders.
Statistical analysis
We examined the relationship between alcohol consumption and
endometrial cancer risk on the basis of the relative risks (RRs) and
95% CIs published in each study. We first performed a meta-
analysis comparing the highest and the lowest alcohol consump-
tion categories within the specific studies. The summary RR
estimate with its 95% CIs were derived with the method
of DerSimonian and Laird (1986) by using the assumption of
a random-effects model, which incorporated between-studies
variability.
We next conducted a dose–response random-effects meta-
regression analysis from the correlated natural log of RRs across
categories of alcohol intake (Greenland and Longnecker, 1992;
Orsini et al, 2006). This method requires that the distribution of
cases and non-cases or person-time and the RR with its variance
estimate for at least three quantitative exposure categories be
known. For missing information, we contacted the relevant
authors (Jain et al, 2000; Kabat et al, 2008; Allen et al, 2009). As
the studies used different units to report alcohol consumption
(e.g., grams or number of drinks per day or week), we expressed
this as drinks per day, considering 13g of alcohol to be equivalent
to one drink; this corresponds to B330ml of beer, 150ml of wine,
or 45ml of hard liquor. For each study, the median (Loerbroks
et al, 2007; Friberg and Wolk, 2009) or mean (Allen et al, 2009)
level of consumption for each category was assigned to each
corresponding RR. When neither was reported, we assigned the
midpoint of the upper and lower bound in each category as the
average intake (Gapstur et al, 1993; Terry et al, 1999; Kabat et al,
2008; Setiawan et al, 2008). If the upper bound in the highest
category was not provided, we assumed that it had the same
amplitude as the preceding category. We used restricted cubic
splines (three knots) to flexibly model and graph the RR (Harrell
et al, 1988).
In all meta-regression models, statistical heterogeneity between
studies was evaluated with Cochran’s Q-test and the I
2 statistic
(Higgins and Thompson, 2002), this being the proportion of total
variation contributed by between-study variation. Publication bias
was assessed by Egger’s regression asymmetry test (Egger et al,
2001). To investigate potential sources of heterogeneity, we
performed a subgroup analysis among studies that adjusted for
confounders, such as smoking, use of oral contraceptives, and
body mass index. Next, a log-linear estimation of the seven
dose–responses was performed. We also conducted a sensitivity
analysis iteratively, excluding each study from the overall
dose–response meta-analysis.
Statistical analyses were carried out with Stata, version 10
(Stata Corp, College Station, TX, USA). P-values that were o0.05
were considered statistically significant. All statistical tests were
two sided.
RESULTS
Seven independent cohort studies met the predefined inclusion
criteria (Table 1), three in North America (Gapstur et al, 1993;
Kabat et al, 2008; Setiawan et al, 2008) and four in Europe (Terry
et al, 1999; Loerbroks et al, 2007; Allen et al, 2009; Friberg and
Wolk, 2009). In total, they included 1511661 participants and 6086
endometrial cancer cases, reported dose–response data on alcohol
and endometrial cancer risk, and a wide range of alcohol intakes.
The comparison of the highest vs lowest category of alcohol intake
(Figure 1) showed an increase in endometrial cancer cases,
although not significantly so (summary RR¼1.17; 95% CI: 0.93–
1.46); we found no evidence of heterogeneity across studies
(Q¼12.0; P¼0.061; I
2¼50%). Furthermore, there was no
evidence for publication bias with regard to alcohol and risk.
The P-value for Egger’s regression asymmetry test was 0.26.
Table 1 Characteristics of prospective cohort studies of alcohol consumption and endometrial cancer incidence
Authors, year
(ref no.)
Study population,
country, follow-up period Case/cohort
Range of exposure
gram alcohol per
day RR (95% CI)
a Controlled variables
Allen et al, 2009 Million Women Study United
Kingdom 1996–2006
4118/1280296 0–24.4
b 0.99 (0.85–1.16) Age, BMI, smoking, PMH, OC,
physical activity, socioeconomic
status, region of residence
Friberg and Wolk,
2009
Swedish Mammography Cohort
1987–2007
687/61226 0–12.4
c 1.09 (0.71–1.68) Age, BMI, smoking, PMH, OC,
parity, age at menarche, age at
menopause, diabetes, education,
energy
Kabat et al, 2008 National Breast Screening Study
Canada 1980–2000
426/89835 0–35
d 0.84 (0.52 –1.36) Age, BMI, PMH, OC, parity, age at
menarche, menopausal status,
education, calories, calcium, raw
vegetables
Setiawan et al, 2008 Multiethnic Cohort USA
1993–2002
324/41574 0–30.0
d 2.01 (1.30–3.11) Age, BMI, smoking, PMH, OC,
parity, age at menarche, age at
menopause, diabetes, hypertension,
vigorous exercise, education, race,
year, study centre
Loerbroks et al, 2007 Netherland Cohort 1986–1997 254/1901 0–37.3
c 1.78 (0.88–3.6) Age, BMI, smoking, OC, parity, age
at first child, age at menopause,
hypertension, physical activity
Terry et al, 1999 Twin Cohort Sweden 1961–1992 117/11659 0–9.5
d 1.3 (0.6–2.8) Age, weight, parity, physical activity
Gapstur et al, 1993 Iowa Womens Health Cohort USA
1986–1990
160/25170 0–6.0
d 1.0 (0.7–1.6) Age, BMI, PMH, parity, age at
menopause
Abbreviations: RR¼relative risk; CI¼confidence interval; BMI¼body mass index; PMH¼postmenopausal hormone use; OC¼oral contraceptive use.
aThe measure of RR
comparing highest vs lowest alcohol category is a rate ratio (hazard ratio) in all studies.
bMean in the lowest–highest category.
cMedian in the lowest–highest category.
dMidpoint
in the lowest–highest category.
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potentially the most important known confounders of an inverse
or of any association between alcohol and endometrial cancer risk.
When we restricted the meta-analysis to studies that controlled for
these variables (Loerbroks et al, 2007; Setiawan et al, 2008; Allen
et al, 2009; Friberg and Wolk, 2009), the summary RR was slightly
higher but remained insignificant (summary RR¼1.33; 95% CI:
0.92–1.91).
In a dose–response analysis, we modelled the relationship
between endometrial cancer risk and alcohol consumption using
restricted cubic splines (Figure 2) and found some evidence of a
non-linear association (P-value for linearity¼0.01). For exposures
less than one drink per day, compared with non-drinkers, risk
was lower by 4% (95% CI: 0.93–1.00) for consumption of up to
0.5 drinks per day and by 7% (95% CI: 0.85-1.02) for 0.5 to 1 drink
per day (1 drink¼13g of ethanol). Risk seemed to increase after
two drinks of alcohol per day, and compared with non-drinkers, it
was higher by 14% (95% CI: 0.95–1.36) for 2–2.5 drinks per day
and by 25% (95% CI: 0.98–1.58) for 2.5 drinks per day or more
(Figure 2). A log-linear estimation of the seven dose–responses
rendered a pooled RR of 1.06 (95% CI: 0.94–1.19) (Q¼13.13;
P¼0.04; I
2¼54%)
In a sensitivity analysis iteratively removing each study from the
overall analysis, we detected a curvilinear association with alcohol
in all subgroups (Figure 3).
DISCUSSION
Our findings suggest that alcohol consumption is weakly
associated with endometrial cancer risk. Dose–response analyses
showed a non-linear association between risk and number of
drinks of alcohol per day: consumption of up to 13g of alcohol per
day (one drink) seemed to be weakly protective, whereas
exposure to more than two drinks (426g of alcohol) per day
may increase risk.
Our analysis must be interpreted in the context of the limited
available data. Some degree of non-differential misclassification of
alcohol exposure is probable, but this would be expected to
attenuate the true relationship. As in all meta-analyses, the
possibility of publication bias is of concern, but was not suggested
by a formal statistical test. Our meta-analysis has several strengths.
First, it was based on prospective studies, which are less
susceptible to bias (e.g., recall and selection bias). Second, the
dose–response analyses included a wide range of alcohol intake.
A relationship between alcohol and risk of endometrial cancer is
biologically plausible. Alcohol increases oestrogen levels (Gavaler
and Van Thiel, 1992; Hankinson et al, 1995; Onland-Moret et al,
2005; Rinaldi et al, 2006), which in turn have been shown to
increase risk by stimulating the proliferation of endometrial cells
(Graham and Clarke, 1997). The EPIC (European Prospective
Investigation into Cancer and Nutrition), which is the largest study
on alcohol consumption and sex-steroid concentrations, observed
a statistically significant increase in blood oestrone levels among
women consuming on an average approximately two drinks per
Overall
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Figure 1 Summary of relative risk (RR) estimates (highest vs lowest
category) of endometrial cancer risk associated with alcohol consumption.
Squares represent study-specific RRs and the sizes of the squares reflect the
statistical weight (inverse of the variance) that each study contributed to
the summary estimate. Horizontal lines represent 95% confidence intervals
(95% CIs), the diamond represents the summary estimate and its 95% CI.
Test for heterogeneity Q¼12.0; P¼0.061; I
2¼50%.
1
0.8
0.9
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
R
e
l
a
t
i
v
e
 
r
i
s
k
0 0.5 1 1.5 2 2.5 3
Alcohol consumption (drinks per day)
Drinks per day
0
>0 – 0.5
>0.5 – 1
>1 – 1.5
>1.5 – 2
>2 – 2.5
> 2.5
RR (95% CI) No. of cases Ref. point
1.00 (Referent)
0.96 (0.93–1.00)
0.93 (0.85–1.02)
0.97 (0.87–1.07)
1.04 (0.92–1.19)
1.14 (0.95–1.36)
1.25 (0.98–1.58) 35
29
231
675
124
2984
1989 0
0.25
0.75
1.25
1.75
2.25
2.75
Figure 2 Dose–response relationship between alcohol consumption
(drink per day) and endometrial cancer risk estimated with a random-effect
meta-regression-restricted cubic spline model. The grey shaded area
represents the 95% confidence limits for the fitted curve. Test for
heterogeneity Q¼26.87; P-heterogeneity¼0.22; I
2¼6.9%.
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Figure 3 Sensitivity analysis of the dose–response relationship between
endometrial cancer risk and alcohol consumption, iteratively removing each
study from the overall analysis.
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Furthermore, an intake of 30g of alcohol per day has been shown
to improve insulin sensitivity and reduce fasting insulin concen-
trations (Davies et al, 2002), thereby potentially decreasing
endometrial cancer risk, although higher intakes do not seem to
have these effects (Carlsson et al, 2005). Insulin has been shown
to stimulate the growth of endometrial stromal cells by binding to
insulin receptors in the endometrium (Nagamani and Stuart,
1998). Hyperinsulinaemia may also increase levels of free
oestrogen through decreasing concentrations of circulating sex
hormone-binding globulin (Nestler et al, 1991; Kazer, 1995).
Finally, hyperinsulinaemia, through decreasing levels of IGFBP-1,
increases circulating free IGF-1, which, by binding and activating
IGF-1 receptors in the endometrium, stimulates cell proliferation
(Corocleanu, 1993; Irwin et al, 1993; Ordener et al, 1993; Murphy,
1994; Thiet et al, 1994; Weiderpass et al, 2003). However, we
cannot rule out the possibility that part of the lowered RR observed
among women drinking up to one drink per day is because the
reference category includes former drinkers and women with
health problems.
Our results have important public health implications, given the
large number of women consuming alcohol, and the increasing
incidence of endometrial cancer in Western societies. The results
from this meta-analysis suggest a J-shaped association between
alcohol intake and endometrial cancer risk. Moderate alcohol
consumption might protect against endometrial cancer, whereas
high alcohol consumption may increase risk.
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